| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |